Results 291 to 300 of about 1,940,457 (361)
Mechanism and regulation of mitophagy in liver diseases: a review. [PDF]
Liu S +9 more
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
New Challenges in the Study of Liver Diseases: From Molecular Pathogenesis to Therapeutic Approaches (3rd Edition). [PDF]
Dongiovanni P, Meroni M.
europepmc +1 more source
Bariatric surgery’s impact on hepatic cirrhosis: a therapeutic bridge in advanced liver disease
Yong Sup Lee +3 more
openalex +1 more source
Therapeutic Potential of Ellagic Acid in Liver Diseases. [PDF]
Wojtunik-Kulesza K +5 more
europepmc +1 more source
Study of Liver Diseases in Pregnancy and Their Implications for Maternal and Fetal Outcomes. [PDF]
Goyal MB, Kirnake V, Goyal M, Shende U.
europepmc +1 more source
Macrophages in Autoimmune Liver Diseases: From Immune Homeostasis to Precision-Targeted Therapy. [PDF]
Liu T, Wang Y, Huang Y, Zhao R, Shen H.
europepmc +1 more source
The shifting burden of gastrointestinal and liver diseases in Southeast Asia and effective control strategies. [PDF]
europepmc +1 more source

